Operating Income (Loss) of BIOADAPTIVES, INC. from 30 Jun 2013 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
BIOADAPTIVES, INC. quarterly and annual Operating Income (Loss) in USD history and change rate from 30 Jun 2013 to 30 Sep 2025.
  • BIOADAPTIVES, INC. Operating Income (Loss) for the quarter ending 30 Sep 2025 was $265,689, a 118% decline year-over-year.
  • BIOADAPTIVES, INC. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was $1,131,395, a 246% decline year-over-year.
  • BIOADAPTIVES, INC. annual Operating Income (Loss) for 2024 was $602,090, a 163% decline from 2023.
  • BIOADAPTIVES, INC. annual Operating Income (Loss) for 2023 was $228,921, a 46% increase from 2022.
  • BIOADAPTIVES, INC. annual Operating Income (Loss) for 2022 was $421,900.
Source SEC data
View on sec.gov
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

BIOADAPTIVES, INC. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,131,395 $265,689 -$143,748 -118% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $987,647 $279,219 -$186,241 -200% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $801,406 $249,148 -$199,316 -400% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $602,090 $337,339 -$275,555 -446% 01 Oct 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
Q3 2024 $326,535 $121,941 -$29,728 -32% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 $296,807 $92,978 -$37,029 -66% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $259,778 $49,832 -$30,857 -163% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 $228,921 $61,784 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 $92,213 01 Jul 2023 30 Sep 2023 10-Q 19 Nov 2024 2024 Q3
Q2 2023 $55,949 01 Apr 2023 30 Jun 2023 10-Q 19 Aug 2024 2024 Q2
Q1 2023 $18,975 01 Jan 2023 31 Mar 2023 10-Q 17 May 2024 2024 Q1
Q3 2016 $188,951 $26,313 +$13,827 +34% 01 Jul 2016 30 Sep 2016 10-Q 18 Nov 2016 2016 Q3
Q2 2016 $202,778 $33,205 +$76,152 +70% 01 Apr 2016 30 Jun 2016 10-Q 18 Aug 2016 2016 Q2
Q1 2016 $278,930 $80,924 -$51,654 -176% 01 Jan 2016 31 Mar 2016 10-Q 23 May 2016 2016 Q1
Q4 2015 $227,276 $48,509 +$2,249,803 +98% 01 Oct 2015 31 Dec 2015 10-K 14 Apr 2016 2015 FY
Q3 2015 $2,477,079 $40,140 -$17,867 -80% 01 Jul 2015 30 Sep 2015 10-Q 18 Nov 2016 2016 Q3
Q2 2015 $2,459,212 $109,357 -$1,903 -1.8% 01 Apr 2015 30 Jun 2015 10-Q 18 Aug 2016 2016 Q2
Q1 2015 $2,457,309 $29,270 -$20,884 -249% 01 Jan 2015 31 Mar 2015 10-Q 23 May 2016 2016 Q1
Q4 2014 $2,436,425 $2,298,312 01 Oct 2014 31 Dec 2014 10-K 14 Apr 2016 2015 FY
Q3 2014 $22,273 -$21,024 -1683% 01 Jul 2014 30 Sep 2014 10-Q 23 Nov 2015 2015 Q3
Q2 2014 $107,454 -$105,954 -7064% 01 Apr 2014 30 Jun 2014 10-Q 21 Aug 2015 2015 Q2
Q1 2014 $8,386 01 Jan 2014 31 Mar 2014 10-Q 20 May 2015 2015 Q1
Q3 2013 $1,249 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014 2014 Q3
Q2 2013 $1,500 19 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014 2014 Q2

BIOADAPTIVES, INC. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $602,090 -$373,169 -163% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
2023 $228,921 +$192,979 +46% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
2022 $421,900 01 Jan 2022 31 Dec 2022 10-K 10 Apr 2024 2023 FY
2015 $227,276 +$2,209,149 +91% 01 Jan 2015 31 Dec 2015 10-K 14 Apr 2016 2015 FY
2014 $2,436,425 -$2,409,260 -8869% 01 Jan 2014 31 Dec 2014 10-K 14 Apr 2016 2015 FY
2013 $27,165 19 Apr 2013 31 Mar 2014 10-Q 20 May 2014 2014 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.